Kwang Yu Chang

Summary

Affiliation: National Health Research Institutes
Country: Taiwan

Publications

  1. pmc Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
    Kwang Yu Chang
    Institute of Clinical Medicine College of Medicine, National Cheng Kung University, 7th Floor, No 35 Xiaodong Rd, Tainan City 701, Taiwan
    J Biomed Sci 20:43. 2013
  2. pmc Tea consumption and risk of head and neck cancer
    Cheng Chih Huang
    Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    PLoS ONE 9:e96507. 2014
  3. doi request reprint Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo
    Kwang Yu Chang
    Institute of Clinical Medicine, Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China
    Clin Cancer Res 17:7116-26. 2011
  4. pmc Allergies and risk of head and neck cancer: an original study plus meta-analysis
    Jenn Ren Hsiao
    Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    PLoS ONE 8:e55138. 2013

Collaborators

  • Jeffrey S Chang
  • Cheng Chih Huang
  • Jenn Ren Hsiao
  • Jehn Shyun Huang
  • Ken Chung Chen
  • Ya Ling Weng
  • Ming Wei Yang
  • Chia Jui Yen
  • Chun Yen Ou
  • Han Chien Yang
  • Sen Tien Tsai
  • Shang Yin Wu
  • Wei Ting Lee
  • Yi Hui Wang
  • Yuan hua Wu
  • Chen Lin Lin
  • Tung Yiu Wong
  • Wei Ting Hsueh
  • Hung I Lo
  • Sheen Yie Fang
  • Forn Chia Lin
  • Jiunn Liang Wu
  • Fang ting Wang

Detail Information

Publications4

  1. pmc Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
    Kwang Yu Chang
    Institute of Clinical Medicine College of Medicine, National Cheng Kung University, 7th Floor, No 35 Xiaodong Rd, Tainan City 701, Taiwan
    J Biomed Sci 20:43. 2013
    ..Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting...
  2. pmc Tea consumption and risk of head and neck cancer
    Cheng Chih Huang
    Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    PLoS ONE 9:e96507. 2014
    ..The current study evaluated the association between tea consumption and head and neck cancer (HNC) in Taiwan, where tea is a major agricultural product and a popular beverage...
  3. doi request reprint Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo
    Kwang Yu Chang
    Institute of Clinical Medicine, Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China
    Clin Cancer Res 17:7116-26. 2011
    ..To develop a new treatment, we investigated the effect of a novel dual PI3K/mTOR inhibitor, NVP-BGT226 (BGT226), in head and neck cancer cells...
  4. pmc Allergies and risk of head and neck cancer: an original study plus meta-analysis
    Jenn Ren Hsiao
    Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    PLoS ONE 8:e55138. 2013
    ..It is not clear whether allergies can independently influence the risk of HNC in the presence of known strong environmental risk factors, including consumption of alcohol, betel quid, and cigarette...